Raji人Burkitt's淋巴瘤细胞

价 格:¥1800

期 货:现货(冻存管发2支)

保藏中心:BTCC

资源编号:BTCC-1147

产地:中国

套 餐:

T25/复苏细胞 无血清冻存液 专用完全培养基500ml 南美特级胎牛血清500ml

详细资料说明书下载质检报告(COA)

Cell line nameRaji
SynonymsRAJI; P1-Raji; GM04671
AccessionBTCC-1147
Resource Identification InitiativeTo cite this cell line use: Raji (BTCC-1147)
CommentsPart of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Part of: ENCODE project common cell types; tier 3.
Part of: LL-100 blood cancer cell line panel.
Part of: MD Anderson Cell Lines Project.
Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
Population: African; Nigerian.
Characteristics: Genetically heterogeneous, consists of 2 subclones (PubMed=27566572).
Virology: Contains 50-60 integrated copies of the EBV genome. One copy is integrated in intron 1 of the BACH2 gene (PubMed=14982850).
Doubling time: 23.2 hours (PubMed=8847894); ~24-36 hours (DSMZ=ACC-319); ~20 hours (HIVReagentProgram=ARP-9944).
Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Omics: Deep exome analysis.
Omics: Deep quantitative proteome analysis.
Omics: DNA methylation analysis.
Omics: H3K27ac ChIP-seq epigenome analysis.
Omics: H3K4me3 ChIP-seq epigenome analysis.
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Omics: Virome analysis using RNAseq.
Misspelling: BAJI; Cosmic=998718.
Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
Sequence variations
HLA typingSource: PubMed=25960936
Class I
HLA-AA*03:01,03:01
HLA-BB*15:10,15:10
HLA-CC*04:01,03:04
Class II
HLA-DQDQA1*05:01,01:01

DQB1*05:01,02:01
HLA-DRDRB1*10:01,03:01

Source: IPD-IMGT/HLA=11295
Class I
HLA-AA*03:01:01:01
HLA-BB*15:10,15:CXU
HLA-CC*03:04:02,04:01:01:01
Class II
HLA-DPDPB1*01:01:01
HLA-DQDQA1*01:01:01,05:01:01:01

DQB1*02:01:01,05:01:01
HLA-DRDRA*01:01:01:01

DRB1*03:01:01:01,10:01:01:01

DRB3*02

Source: CLS=300359
Class I
HLA-AA*03:01:01
HLA-BB*15:10:01
HLA-CC*03:04:02,04:01:01
Class II
HLA-DPDPB1*01:01:01
HLA-DQDQA1*01:05:01,05:01:01

DQB1*02:01:01,05:01:01
HLA-DRDRB1*03:01:01,10:01:01

Source: DSMZCellDive=ACC-319
Class I
HLA-AA*03:01:01,03:01:01
HLA-BB*15:10:01,15:10:01
HLA-CC*03:04:02,04:01:01
Class II
HLA-DPDPA1*02:02:02,02:02:02

DPB1*01:01:01,01:01:01
HLA-DQDQA1*01:05:01,05:01:01

DQB1*02:01:01,05:01:01
HLA-DRDRA*01:01:01,01:01:01

DRB1*03:01:01,10:01:01
Genome ancestrySource: PubMed=30894373

Origin% genome


African99.39
Native American0
East Asian, North0.6
East Asian, South0
South Asian0
European, North0
European, South0
DiseaseEBV-related Burkitt lymphoma (NCIt: C27694)
Burkitt lymphoma (ORDO: Orphanet_543)
Species of originHomo sapiens (Human) (NCBI Taxonomy: 9606)
HierarchyChildren:



CVCL_B7VS (Abcam Raji AATF KO)CVCL_B7VT (Abcam Raji ABCB1 KO)CVCL_B7VU (Abcam Raji AGTR1 KO)
CVCL_B7VV (Abcam Raji AHR KO)CVCL_B7VW (Abcam Raji AIM2 KO)CVCL_B7VX (Abcam Raji ALCAM KO)
CVCL_B7VY (Abcam Raji ALKBH1 KO)CVCL_B7VZ (Abcam Raji ALYREF KO)CVCL_B7W0 (Abcam Raji APOBEC3B KO)
CVCL_B7W1 (Abcam Raji ASAH1 KO)CVCL_B7W2 (Abcam Raji ATF5 KO)CVCL_B7W3 (Abcam Raji ATG3 KO)
CVCL_B7W4 (Abcam Raji ATG9A KO)CVCL_B7W5 (Abcam Raji BAK1 KO)CVCL_B7W6 (Abcam Raji BMPR2 KO)
CVCL_B7W7 (Abcam Raji BRD1 KO)CVCL_B7W8 (Abcam Raji BRD2 KO)CVCL_B7W9 (Abcam Raji BRD9 KO)
CVCL_B7WA (Abcam Raji BTG1 KO)CVCL_B7WB (Abcam Raji BTK KO)CVCL_B7WC (Abcam Raji BTRC KO)
CVCL_B7WD (Abcam Raji C3 KO)CVCL_B7WE (Abcam Raji CASP3 KO)CVCL_B7WF (Abcam Raji CCRL2 KO)
CVCL_B7WG (Abcam Raji CCL22 KO)CVCL_B1BK (Abcam Raji CD27 KO)CVCL_B7WH (Abcam Raji CD36 KO)
CVCL_B7WI (Abcam Raji CD48 KO)CVCL_B7WJ (Abcam Raji CD58 KO)CVCL_B7WK (Abcam Raji CD59 KO)
CVCL_B1BL (Abcam Raji CD74 KO 1)CVCL_B1BM (Abcam Raji CD74 KO 2)CVCL_B8AM (Abcam Raji CD79A KO)
CVCL_B1BN (Abcam Raji CD80 KO)CVCL_B7WL (Abcam Raji CD81 KO)CVCL_B7WM (Abcam Raji CD83 KO)
CVCL_B1BP (Abcam Raji CD86 KO)CVCL_B7WN (Abcam Raji CITED2 KO)CVCL_B7WP (Abcam Raji CLU KO)
CVCL_B7WQ (Abcam Raji CMKLR1 KO)CVCL_B7WR (Abcam Raji CMTM6 KO)CVCL_B7WS (Abcam Raji CNR2 KO)
CVCL_B7WT (Abcam Raji CST3 KO)CVCL_B7WU (Abcam Raji CTSB KO)CVCL_B7WV (Abcam Raji CUL2 KO)
CVCL_B7WW (Abcam Raji CUL3 KO)CVCL_B7WX (Abcam Raji CUL4B KO)CVCL_B1BQ (Abcam Raji CXCR5 KO)
CVCL_B7WY (Abcam Raji CXXC1 KO)CVCL_B7WZ (Abcam Raji DCP2 KO)CVCL_B7X0 (Abcam Raji DLL1 KO)
CVCL_B7X1 (Abcam Raji DVL3 KO)CVCL_B7X2 (Abcam Raji EGLN1 KO)CVCL_B7X3 (Abcam Raji EHMT2 KO)
CVCL_B7X4 (Abcam Raji EIF2AK4 KO)CVCL_B7X5 (Abcam Raji EPHB4 KO)CVCL_B7X6 (Abcam Raji ERAP1 KO)
CVCL_B7X7 (Abcam Raji ETS2 KO)CVCL_B7X8 (Abcam Raji EXO1 KO)CVCL_B7X9 (Abcam Raji FABP4 KO)
CVCL_B7XA (Abcam Raji FKBP5 KO)CVCL_B7XB (Abcam Raji FOXO1 KO)CVCL_B7XC (Abcam Raji FOXO3 KO)
CVCL_B7XD (Abcam Raji FST KO)CVCL_B7XE (Abcam Raji FTL KO)CVCL_B7XF (Abcam Raji FZD7 KO)
CVCL_B7XG (Abcam Raji GAB1 KO)CVCL_B7XH (Abcam Raji GLB1 KO)CVCL_B7XI (Abcam Raji GPR132 KO)
CVCL_B7XJ (Abcam Raji GZMA KO)CVCL_B7XK (Abcam Raji HLA-B KO)CVCL_B7XL (Abcam Raji HNF1B KO)
CVCL_B7XM (Abcam Raji HSPG2 KO)CVCL_B7XN (Abcam Raji ID2 KO)CVCL_B7XP (Abcam Raji IL17RB KO)
CVCL_B7XQ (Abcam Raji ITPR3 KO)CVCL_B7XR (Abcam Raji JAG1 KO)CVCL_B7XS (Abcam Raji JMJD6 KO)
CVCL_B7XT (Abcam Raji KAT7 KO)CVCL_B7XU (Abcam Raji KDM1B KO)CVCL_B7XV (Abcam Raji KDM6B KO)
CVCL_B7XW (Abcam Raji KPNA2 KO)CVCL_B7XX (Abcam Raji LAIR1 KO)CVCL_B7XY (Abcam Raji LAMP2 KO)
CVCL_B7XZ (Abcam Raji LDHA KO)CVCL_B7Y0 (Abcam Raji LGR6 KO)CVCL_B7Y1 (Abcam Raji LMNB1 KO)
CVCL_B7Y2 (Abcam Raji MACROH2A1 KO)CVCL_B7Y3 (Abcam Raji MAGEA3 KO)CVCL_B7Y4 (Abcam Raji MAP2K3 KO)
CVCL_B7Y5 (Abcam Raji MAP3K3 KO)CVCL_B7Y6 (Abcam Raji MAPK7 KO)CVCL_B7Y7 (Abcam Raji MBD1 KO)
CVCL_B7Y8 (Abcam Raji MBD3 KO)CVCL_B7Y9 (Abcam Raji MME KO)CVCL_B7YA (Abcam Raji MMP13 KO)
CVCL_B7YB (Abcam Raji MMP8 KO)CVCL_B7YC (Abcam Raji MS4A1 KO)CVCL_B7YD (Abcam Raji MTA3 KO)
CVCL_B7YE (Abcam Raji NBR1 KO)CVCL_B7YF (Abcam Raji NCR3LG1 KO)CVCL_B7YG (Abcam Raji NFATC2 KO)
CVCL_B7YH (Abcam Raji NFKB1 KO)CVCL_B7YI (Abcam Raji NLRC4 KO)CVCL_B7YJ (Abcam Raji NOTCH3 KO)
CVCL_B7YK (Abcam Raji NOTCH4 KO)CVCL_B7YL (Abcam Raji NR1H4 KO)CVCL_B7YM (Abcam Raji NR3C2 KO)
CVCL_B7YN (Abcam Raji PDCD1LG2 KO)CVCL_B7YP (Abcam Raji PHF8 KO)CVCL_B7YQ (Abcam Raji PIK3CA KO)
CVCL_B7YR (Abcam Raji PIK3CD KO)CVCL_B7YS (Abcam Raji PIK3R4 KO)CVCL_B7YT (Abcam Raji PLA2G4A KO)
CVCL_B7YU (Abcam Raji PLCB3 KO)CVCL_B7YV (Abcam Raji PLCG1 KO)CVCL_B7YW (Abcam Raji PRMT7 KO)
CVCL_B7YX (Abcam Raji PSEN1 KO)CVCL_B7YY (Abcam Raji PTGER4 KO)CVCL_B7YZ (Abcam Raji PTGES2 KO)
CVCL_B7Z0 (Abcam Raji PTK2 KO)CVCL_B7Z1 (Abcam Raji PTP4A3 KO)CVCL_B7Z2 (Abcam Raji PTPN12 KO)
CVCL_B7Z3 (Abcam Raji PUS1 KO)CVCL_B7Z4 (Abcam Raji RAC2 KO)CVCL_B7Z5 (Abcam Raji RING1 KO)
CVCL_B7Z6 (Abcam Raji ROCK2 KO)CVCL_B7Z7 (Abcam Raji ROR2 KO)CVCL_B7Z8 (Abcam Raji RYBP KO)
CVCL_B7Z9 (Abcam Raji SCARB1 KO)CVCL_B7ZA (Abcam Raji SDC4 KO)CVCL_B7ZB (Abcam Raji SETD2 KO)
CVCL_B7ZC (Abcam Raji SLFN11 KO)CVCL_B7ZD (Abcam Raji SMARCAL1 KO)CVCL_B7ZE (Abcam Raji SMARCC2 KO)
CVCL_B7ZF (Abcam Raji SMARCE1 KO)CVCL_B7ZG (Abcam Raji SMURF1 KO)CVCL_B7ZH (Abcam Raji SMYD2 KO)
CVCL_B7ZI (Abcam Raji SMYD3 KO)CVCL_B7ZJ (Abcam Raji SOCS3 KO)CVCL_B7ZK (Abcam Raji SRF KO)
CVCL_B7ZL (Abcam Raji SRPK1 KO)CVCL_B7ZM (Abcam Raji STAT4 KO)CVCL_B7ZN (Abcam Raji STAT5A KO)
CVCL_B7ZP (Abcam Raji STK4 KO)CVCL_B7ZQ (Abcam Raji SUV39H1 KO)CVCL_B7ZR (Abcam Raji SUZ12 KO)
CVCL_B7ZS (Abcam Raji TAPBP KO)CVCL_B7ZT (Abcam Raji TBK1 KO)CVCL_B7ZU (Abcam Raji TBP KO)
CVCL_B7ZV (Abcam Raji TCF7L2 KO)CVCL_B7ZW (Abcam Raji TFDP1 KO)CVCL_B7ZX (Abcam Raji TIMP3 KO)
CVCL_B7ZY (Abcam Raji TLN1 KO)CVCL_B7ZZ (Abcam Raji TNFRSF10B KO)CVCL_B8A0 (Abcam Raji TNFRSF1B KO)
CVCL_B8A1 (Abcam Raji TP73 KO)CVCL_B8A2 (Abcam Raji TRADD KO)CVCL_B8A3 (Abcam Raji TRAF2 KO)
CVCL_B8A4 (Abcam Raji TRMT2A KO)CVCL_B8A5 (Abcam Raji TWIST1 KO)CVCL_B8A6 (Abcam Raji TWIST2 KO)
CVCL_B8A7 (Abcam Raji U2AF1 KO)CVCL_B8A8 (Abcam Raji UBA1 KO)CVCL_B8A9 (Abcam Raji UBE2D2 KO)
CVCL_B8AA (Abcam Raji UCHL5 KO)CVCL_B8AB (Abcam Raji ULBP3 KO)CVCL_B8AC (Abcam Raji UVRAG KO)
CVCL_B8AD (Abcam Raji VAV1 KO)CVCL_B8AE (Abcam Raji VCAN KO)CVCL_B8AF (Abcam Raji WDR77 KO)
CVCL_B8AG (Abcam Raji WNT11 KO)CVCL_B8AH (Abcam Raji YTHDC2 KO)CVCL_B8AI (Abcam Raji YTHDF1 KO)
CVCL_B8AJ (Abcam Raji YTHDF3 KO)CVCL_B8AK (Abcam Raji YY1 KO)CVCL_B8AL (Abcam Raji ZEB2 KO)
CVCL_0R19 (B-THP-1)CVCL_B3QL (MTX-RAJI)CVCL_3042 (NC-37)
CVCL_UJ11 (R/ADR)CVCL_UJ12 (R/VP-16)CVCL_2699 (RAJI 'A')
CVCL_Y035 (Raji 6-TGR)CVCL_C3CD (Raji B2M KO)CVCL_YN94 (Raji CD19 Knockout)
CVCL_2700 (RAJI TK+)CVCL_2701 (RAJI TK-)CVCL_A7ZV (Raji-h4-1BB)
CVCL_A7ZW (Raji-hCTLA4)CVCL_A7ZX (Raji-hEGFR)CVCL_A7ZY (Raji-HER2)
CVCL_A7ZZ (Raji-hICOS)CVCL_A8AA (Raji-hLAG3)CVCL_A8AC (Raji-hOX40)
CVCL_A8AD (Raji-hPD-1)CVCL_A8AE (Raji-hPD-L1)CVCL_A8AF (Raji-hTIGIT)
CVCL_A8AG (Raji-hVISTA)CVCL_A8AB (Raji-Null)CVCL_VL72 (Raji(A44))
CVCL_LK62 (Raji-GFP)CVCL_DD98 (Raji-TG)CVCL_KU31 (Raji/18V)
CVCL_C0HU (Raji/A)CVCL_0R22 (Raji/DC-SIGN)CVCL_3414 (Rj2.2.5)
CVCL_ZI13 (RUD)CVCL_C5DL (sfRaji)CVCL_8431 (TDL-4)
Sex of cellMale
Age at sampling11Y
CategoryCancer cell line
STR profileSource(s): AddexBio; ATCC; CCRID; CLS; Cosmic-CLP; DSMZ; ECACC; Genomics_Center_BCF_Technion; JCRB; PubMed=11416159; PubMed=25877200; RCB; TKG

Markers:
AmelogeninX,Y
CSF1PO10,12
D1S165614
D2S44111,12
D2S133822 (CCRID; Genomics_Center_BCF_Technion)
21,22 (DSMZ)
D3S135815,16
D5S81810,13
D7S82010
D8S117914,15
D10S124812,13
D12S39118,19
D13S31713
D16S5398,11
D18S5117
D19S43314,14.2 (CCRID; Genomics_Center_BCF_Technion)
14,15 (DSMZ)
D21S1128,31
D22S104515,18
DYS39110
FGA19,27
Penta D3.2,9 (CLS; Genomics_Center_BCF_Technion; PubMed=25877200)
3.2,9,10 (DSMZ)
Penta E5,13
TH016,7
TPOX8,13
vWA16,19

Run an STR similarity search on this cell line
Web pageshttps://en.wikipedia.org/wiki/Raji_cell
https://www.atcc.org/en/support/technical-support/faqs/ccl-86-morphology-and-growth
http://genome.ucsc.edu/ENCODE/protocols/cell/human/Raji_Farnham_protocol.pdf
https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/r/cell-lines-detail-27.html
https://tcpaportal.org/mclp/
Publications

PubMed=14086209; DOI=10.1016/S0140-6736(64)92345-1
Pulvertaft R.J.V., Cantab M.D.
Cytology of Burkitt's tumour (African lymphoma).
Lancet 283:238-240(1964)

PubMed=4169243; DOI=10.1093/jnci/39.5.1027
Klein G., Clifford P., Klein E., Smith R.T., Minowada J., Kourilsky F.M., Burchenal J.H.
Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures.
J. Natl. Cancer Inst. 39:1027-1044(1967)

PubMed=6018567
Miles C.P., O'Neill F.
Chromosome studies of 8 in vitro lines of Burkitt's lymphoma.
Cancer Res. 27:392-402(1967)

PubMed=4894370; DOI=10.1002/1097-0142(196908)24:2<211::aid-cncr2820240202>3.0.CO;2-3
Southam C.M., Burchenal J.H., Clarkson B.D., Tanzi A., Mackey R., McComb V.
Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats.
Cancer 24:211-222(1969)

DOI=10.1007/BF02618370
Stulberg C.S., Coriell L.L., Kniazeff A.J., Shannon J.E.
The animal cell culture collection.
In Vitro 5:1-16(1970)

PubMed=4321017; DOI=10.1002/ijc.2910060315
Durr F.E., Monroe J.H., Schmitter R., Traul K.A., Hirshaut Y.
Studies on the infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cells.
Int. J. Cancer 6:436-449(1970)

PubMed=4321974
Maurer B.A., Wilbert S.M., Imamura T.
Incidence of EB virus-containing cells in primary and secondary clones of several Burkitt lymphoma cell lines.
Cancer Res. 30:2870-2875(1970)

PubMed=4325933; DOI=10.1093/jnci/46.6.1243
Pearson G.R., Henle G., Henle W.
Production of antigens associated with Epstein-Barr virus in experimentally infected lymphoblastoid cell lines.
J. Natl. Cancer Inst. 46:1243-1250(1971)

PubMed=4122458; DOI=10.1002/ijc.2910100108
Klein G., Dombos L., Gothoskar B.
Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
Int. J. Cancer 10:44-57(1972)

PubMed=4347031; DOI=10.1093/jnci/48.1.87
Hewetson J.F., Gothoskar B., Klein G.
Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus.
J. Natl. Cancer Inst. 48:87-94(1972)

PubMed=4550511; DOI=10.1073/pnas.69.1.78
Hampar B., Derge J.G., Martos L.M., Walker J.L.
Synthesis of Epstein-Barr virus after activation of the viral genome in a 'virus-negative' human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine.
Proc. Natl. Acad. Sci. U.S.A. 69:78-82(1972)

PubMed=4364259; DOI=10.1002/ijc.2910110210
Klein G., Dombos L.
Relationship between the sensitivity of EBV-carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome.
Int. J. Cancer 11:327-337(1973)

PubMed=4736620; DOI=10.1111/j.1469-1809.1973.tb00588.x
Povey S., Gardiner S.E., Watson B., Mowbray S., Harris H., Arthur E., Steel C.M., Blenkinsop C., Evans H.J.
Genetic studies on human lymphoblastoid lines: isozyme analysis on cell lines from forty-one different individuals and on mutants produced following exposure to a chemical mutagen.
Ann. Hum. Genet. 36:247-266(1973)

PubMed=4366935
Minowada J., Nonoyama M., Moore G.E., Rauch A.M., Pagano J.S.
The presence of the Epstein-Barr viral genome in human lymphoblastoid B-cell lines and its absence in a myeloma cell line.
Cancer Res. 34:1898-1903(1974)

PubMed=170370; DOI=10.1099/0022-1317-28-2-207
Adams A., Strander H., Cantell K.
Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.
J. Gen. Virol. 28:207-217(1975)

PubMed=1086134
Kaplan J., Peterson W.D. Jr.
Detection of T-cell lymphoma-associated antigens on cord blood lymphocytes and phytohemagglutinin-stimulated blasts.
Cancer Res. 36:3471-3475(1976)

PubMed=216485
Higgins N.P., Strauss B.S.
Differences in the ability of human lymphoblastoid lines to exclude bromodeoxyuridine and in their sensitivity to methyl methanesulfonate and to incorporated [3H]thymidine.
Cancer Res. 39:312-320(1979)

PubMed=7316467; DOI=10.1111/j.1469-1809.1980.tb00953.x
Povey S., Jeremiah S., Arthur E., Steel M., Klein G.
Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy.
Ann. Hum. Genet. 44:119-133(1980)

PubMed=6265077
Pizzo P.A., Chattopadhyay S.K., Magrath I.T., Del Giacco E., Sherrick D., Gray T.
Examination of Epstein-Barr virus and C-type proviral sequences in American and African lymphomas and derivative cell lines.
Cancer Res. 41:3165-3171(1981)

PubMed=6286763; DOI=10.4049/jimmunol.129.3.1336
Benjamin D., Magrath I.T., Maguire R.T., Janus C., Todd H.D., Parsons R.G.
Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.
J. Immunol. 129:1336-1342(1982)

PubMed=6806672; DOI=10.1038/298474a0
Lenoir G.M., Preud'homme J.-L., Bernheim A., Berger R.
Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma.
Nature 298:474-476(1982)

PubMed=6954533; DOI=10.1073/pnas.79.7.2194
Westin E.H., Gallo R.C., Arya S.K., Eva A., Souza L.M., Baluda M.A., Aaronson S.A., Wong-Staal F.
Differential expression of the amv gene in human hematopoietic cells.
Proc. Natl. Acad. Sci. U.S.A. 79:2194-2198(1982)

PubMed=7060222; DOI=10.1016/0009-2797(82)90007-2
Meltz M.L., Whittam N.J., Thornburg W.H.
Reassociation of human lymphoblastoid cell DNA repair replicated following methyl methanesulfonate treatment.
Chem. Biol. Interact. 39:77-88(1982)

PubMed=6306472; DOI=10.1038/304135a0
Hamlyn P.H., Rabbitts T.H.
Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene.
Nature 304:135-139(1983)

PubMed=6419122; DOI=10.1038/306760a0
Rabbitts T.H., Hamlyn P.H., Baer R.
Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma.
Nature 306:760-765(1983)

PubMed=6600440; DOI=10.1007/BF02617996
Uittenbogaart C.H., Cantor Y., Fahey J.L.
Growth of human malignant lymphoid cell lines in serum-free medium.
In Vitro 19:67-72(1983)

PubMed=6231253; DOI=10.1002/ijc.2910330407
Ehlin-Henriksson B., Klein G.
Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation.
Int. J. Cancer 33:459-463(1984)

PubMed=6500159; DOI=10.1159/000163283
Gershwin M.E., Lentz D., Owens R.B.
Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice.
Exp. Cell Biol. 52:361-370(1984)

PubMed=6547209; DOI=10.1038/309592a0
Rabbitts T.H., Forster A., Hamlyn P.H., Baer R.
Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.
Nature 309:592-597(1984)

PubMed=6582512; DOI=10.1073/pnas.81.2.568
Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984)

PubMed=6592381; DOI=10.1093/jnci/73.4.841
Favrot M.C., Philip I., Philip T., Portoukalian J., Dore J.-F., Lenoir G.M.
Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.
J. Natl. Cancer Inst. 73:841-847(1984)

PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0
Drexler H.G., Gaedicke G., Minowada J.
Isoenzyme studies in human leukemia-lymphoma cell lines -- 1 carboxylic esterase.
Leuk. Res. 9:209-229(1985)

PubMed=2998993
Steel C.M., Morten J.E.N., Foster E.
The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
IARC Sci. Publ. 60:265-292(1985)

PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1
Drexler H.G., Gaedicke G., Minowada J.
Isoenzyme studies in human leukemia-lymphoma cell lines -- III Beta-hexosaminidase (E.C. 3.2.1.30).
Leuk. Res. 9:549-559(1985)

PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x
Drexler H.G., Gaedicke G., Minowada J.
Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid phosphatase.
Leuk. Res. 9:537-548(1985)

PubMed=3905596
Favrot M.C., Philip I., Philip T., Cabrillat H., Pinatel C., Dore J.-F., Lenoir G.M.
Immunophenotypic classification of 28 Burkitt cell lines with monoclonal antibodies and reagent selection for bone-marrow purging.
IARC Sci. Publ. 60:447-452(1985)

PubMed=3080238
Sieverts H., Alabaster O., Goldschmidts W., Magrath I.T.
Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell lines.
Cancer Res. 46:1182-1188(1986)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=3026973; DOI=10.1002/ijc.2910390215
Ehlin-Henriksson B., Manneborg-Sandlund A., Klein G.
Expression of B-cell-specific markers in different Burkitt lymphoma subgroups.
Int. J. Cancer 39:211-218(1987)

PubMed=3034807; DOI=10.1002/ijc.2910390622
Ohno H., Fukuhara S., Takahashi R., Mihara K.-I., Sugiyama T., Doi S., Uchino H., Toyoshima K.
c-yes and bcl-2 genes located on 18q21.3 in a follicular lymphoma cell line carrying a t(14;18) chromosomal translocation.
Int. J. Cancer 39:785-788(1987)

PubMed=2470097; DOI=10.1073/pnas.86.9.3257
Shtivelman E., Henglein B., Groitl P., Lipp M., Bishop J.M.
Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma.
Proc. Natl. Acad. Sci. U.S.A. 86:3257-3260(1989)

PubMed=2140233; DOI=10.1111/j.1440-1827.1990.tb01549.x
Nakano A., Harada T., Morikawa S., Kato Y.
Expression of leukocyte common antigen (CD45) on various human leukemia/lymphoma cell lines.
Acta Pathol. Jpn. 40:107-115(1990)

PubMed=1915267; DOI=10.1002/j.1460-2075.1991.tb07837.x
Farrell P.J., Allan G.J., Shanahan F., Vousden K.H., Crook T.
p53 is frequently mutated in Burkitt's lymphoma cell lines.
EMBO J. 10:2879-2887(1991)

CLPUB00447
Mulivor R.A., Suchy S.F.
1992/1993 catalog of cell lines. NIGMS human genetic mutant cell repository. 16th edition. October 1992.
(In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992)

CLPUB00458
Treichel R.S.
Susceptibility to LAK-mediated cytotoxicity of multidrug-resistant variants of the human RAJI cell line is not related to expression of major cellular adhesion molecules.
Ohio J. Sci. 93:14-18(1993)

PubMed=8316623; DOI=10.2307/3578190
Evans H.H., Ricanati M., Horng M.-F., Jiang Q.-Y., Mencl J., Olive P.L.
DNA double-strand break rejoining deficiency in TK6 and other human B-lymphoblast cell lines.
Radiat. Res. 134:307-315(1993)

PubMed=8344493; DOI=10.1096/fasebj.7.10.8344493
Bhatia K.G., Goldschmidts W., Gutierrez M.I., Gaidano G., Dalla-Favera R., Magrath I.T.
Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect.
FASEB J. 7:951-956(1993)

PubMed=8515068; DOI=10.4049/jimmunol.150.12.5418
Jain V.K., Judde J.-G., Max E.E., Magrath I.T.
Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
J. Immunol. 150:5418-5428(1993)

PubMed=7849311; DOI=10.1182/blood.V85.4.893.bloodjournal854893
Stranks G., Height S.E., Mitchell P., Jadayel D.M., Yuille M.A.R., De Lord C., Clutterbuck R.D., Treleaven J.G., Powles R.L., Nacheva E., Oscier D.G., Karpas A., Lenoir G.M., Smith S.D., Millar J.L., Catovsky D., Dyer M.J.S.
Deletions and rearrangement of CDKN2 in lymphoid malignancy.
Blood 85:893-901(1995)

PubMed=8547074; DOI=10.1111/j.1365-2141.1995.tb05302.x
Siebert R., Willers C.P., Schramm A., Fossa A., Dresen I.M.G., Uppenkamp M., Nowrousian M.R., Seeber S., Opalka B.
Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.
Br. J. Haematol. 91:350-354(1995)

PubMed=8558913
Morita S., Tsuchiya S., Fujie H., Itano M., Ohashi Y., Minegishi M., Imaizumi M., Endo M., Takano N., Konno T.
Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture.
Leukemia 10:102-105(1996)

PubMed=8847894
Tani A., Tatsumi E., Nakamura F., Kumagai S., Kosaka Y., Sano K., Nakamura H., Amakawa R., Ohno H.
Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines.
Leukemia 10:1592-1603(1996)

PubMed=9192833
Cherney B.W., Bhatia K.G., Sgadari C., Gutierrez M.I., Mostowski H.S., Pike S.E., Gupta G., Magrath I.T., Tosato G.
Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.
Cancer Res. 57:2508-2515(1997)

PubMed=9473234; DOI=10.1182/blood.V91.5.1680
Klangby U., Okan I., Magnusson K.P., Wendland M., Lind P., Wiman K.G.
p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma.
Blood 91:1680-1687(1998)

PubMed=9510473; DOI=10.1111/j.1349-7006.1998.tb00476.x
Hosoya N., Hangaishi A., Ogawa S., Miyagawa K., Mitani K., Yazaki Y., Hirai H.
Frameshift mutations of the hMSH6 gene in human leukemia cell lines.
Jpn. J. Cancer Res. 89:33-39(1998)

PubMed=9685479; DOI=10.1093/nar/26.16.3651
Hultdin M., Gronlund E., Norrback K.-F., Eriksson-Lindstrom E., Just T., Roos G.
Telomere analysis by fluorescence in situ hybridization and flow cytometry.
Nucleic Acids Res. 26:3651-3656(1998)

PubMed=9737686; DOI=10.1038/sj.leu.2401112
Zhang W., Ohnishi K., Shigeno K., Fujisawa S., Naito K., Nakamura S., Takeshita K., Takeshita A., Ohno R.
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
Leukemia 12:1383-1391(1998)

PubMed=9738977; DOI=10.1111/j.1349-7006.1998.tb03275.x
Takizawa J., Suzuki R., Kuroda H., Utsunomiya A., Kagami Y., Joh T., Aizawa Y., Ueda R., Seto M.
Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.
Jpn. J. Cancer Res. 89:712-718(1998)

PubMed=9787181; DOI=10.1182/blood.V92.9.3410
Sakai A., Thieblemont C., Wellmann A., Jaffe E.S., Raffeld M.
PTEN gene alterations in lymphoid neoplasms.
Blood 92:3410-3415(1998)

PubMed=9973220
Gutierrez M.I., Cherney B.W., Hussain A., Mostowski H.S., Tosato G., Magrath I.T., Bhatia K.G.
Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis.
Cancer Res. 59:696-703(1999)

PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4
Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.
Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines.
Leuk. Res. 24:255-262(2000)

PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1
Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.
Corrigendum to: Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24 (2000),255-262.
Leuk. Res. 25:275-278(2001)

PubMed=12145705; DOI=10.1038/sj.leu.2402519
Langerak A.W., Moreau E., van Gastel-Mol E.J., van der Burg M., van Dongen J.J.M.
Detection of clonal EBV episomes in lymphoproliferations as a diagnostic tool.
Leukemia 16:1572-1573(2002)

PubMed=12967475; DOI=10.1111/j.1349-7006.2003.tb01518.x
Maesako Y., Uchiyama T., Ohno H.
Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma.
Cancer Sci. 94:774-781(2003)

PubMed=14982850; DOI=10.1016/S0002-9440(10)63184-7
Takakuwa T., Luo W.-J., Ham M.F., Sakane-Ishikawa E., Wada N., Aozasa K.
Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression.
Am. J. Pathol. 164:967-974(2004)

PubMed=15028022; DOI=10.1111/j.1440-1827.2004.01612.x
Kamimura K., Hojo H., Abe M.
Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: relationship between its expression and prognosis.
Pathol. Int. 54:224-230(2004)

PubMed=15457187; DOI=10.1038/sj.leu.2403534
Karpova M.B., Schoumans J., Ernberg I., Henter J.-I., Nordenskjold M., Fadeel B.
Raji revisited: cytogenetics of the original Burkitt's lymphoma cell line.
Leukemia 19:159-161(2005)

PubMed=15901131; DOI=10.1016/j.prp.2005.01.002
Murai Y., Hayashi S., Takahashi H., Tsuneyama K., Takano Y.
Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines.
Pathol. Res. Pract. 201:109-115(2005)

PubMed=18357372; DOI=10.3892/or.19.4.889
Pop I., Pop L., Vitetta E.S., Ghetie M.-A.
Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein.
Oncol. Rep. 19:889-895(2008)

PubMed=19358282; DOI=10.1002/ijc.24351
Inagaki A., Ishida T., Yano H., Ishii T., Kusumoto S., Ito A., Ri M., Mori F., Ding J., Komatsu H., Iida S., Ueda R.
Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC.
Int. J. Cancer 125:212-221(2009)

PubMed=20164919; DOI=10.1038/nature08768
Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Signatures of mutation and selection in the cancer genome.
Nature 463:893-898(2010)

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

PubMed=20454443; DOI=10.1155/2010/904767
Uphoff C.C., Denkmann S.A., Steube K.G., Drexler H.G.
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines.
J. Biomed. Biotechnol. 2010:904767.1-904767.23(2010)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=22885699; DOI=10.1038/nature11378
Schmitz R., Young R.M., Ceribelli M., Jhavar S., Xiao W.-M., Zhang M.-L., Wright G., Shaffer A.L. III, Hodson D.J., Buras E., Liu X.-L., Powell J.I., Yang Y.-D., Xu W.-H., Zhao H., Kohlhammer H., Rosenwald A., Kluin P., Muller-Hermelink H.-K., Ott G., Gascoyne R.D., Connors J.M., Rimsza L.M., Campo E., Jaffe E.S., Delabie J., Smeland E.B., Ogwang M.D., Reynolds S.J., Fisher R.I., Braziel R.M., Tubbs R.R., Cook J.R., Weisenburger D.D., Chan W.C., Pittaluga S., Wilson W., Waldmann T.A., Rowe M., Mbulaiteye S.M., Rickinson A.B., Staudt L.M.
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
Nature 490:116-120(2012)

PubMed=24590883; DOI=10.1002/gcc.22161
Murga Penas E.-M., Schilling G., Behrmann P., Klokow M., Vettorazzi E., Bokemeyer C., Dierlamm J.
Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
Genes Chromosomes Cancer 53:497-515(2014)

PubMed=25960936; DOI=10.4161/21624011.2014.954893
Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.
A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.
OncoImmunology 3:e954893.1-e954893.12(2014)

PubMed=25355872; DOI=10.1128/JVI.02570-14
Cao S.-B., Strong M.J., Wang X., Moss W.N., Concha M., Lin Z., O'Grady T., Baddoo M., Fewell C., Renne R., Flemington E.K.
High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.
J. Virol. 89:713-729(2015)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S., Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.-M.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=27566572; DOI=10.18632/oncotarget.11524
Quentmeier H., Pommerenke C., Ammerpohl O., Geffers R., Hauer V., MacLeod R.A.F., Nagel S., Romani J., Rosati E., Rosen A., Uphoff C.C., Zaborski M., Drexler H.G.
Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation.
Oncotarget 7:63456-63465(2016)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P., Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

PubMed=29892436; DOI=10.1098/rsos.172472
Shioda S., Kasai F., Watanabe K., Kawakami K., Ohtani A., Iemura M., Ozawa M., Arakawa A., Hirayama N., Kawaguchi E., Tano T., Miyata S., Satoh M., Shimizu N., Kohara A.
Screening for 15 pathogenic viruses in human cell lines registered at the JCRB Cell Bank: characterization of in vitro human cells by viral infection.
R. Soc. Open Sci. 5:172472-172472(2018)

PubMed=30285677; DOI=10.1186/s12885-018-4840-5
Tan K.-T., Ding L.-W., Sun Q.-Y., Lao Z.-T., Chien W., Ren X., Xiao J.-F., Loh X.-Y., Xu L., Lill M., Mayakonda A., Lin D.-C., Yang H., Koeffler H.P.
Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.
BMC Cancer 18:940.1-940.13(2018)

PubMed=30629668; DOI=10.1371/journal.pone.0210404
Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.
Screening human cell lines for viral infections applying RNA-Seq data analysis.
PLoS ONE 14:E0210404-E0210404(2019)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=31068700; DOI=10.1038/s41586-019-1186-3
Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature 569:503-508(2019)

PubMed=31160637; DOI=10.1038/s41598-019-44491-x
Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K., Uphoff C.C., Drexler H.G.
The LL-100 panel: 100 cell lines for blood cancer studies.
Sci. Rep. 9:8218-8218(2019)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

Cross-references
Cell line databases/resourcesCLO; CLO_0008734
CLO; CLO_0019014
CLO; CLO_0050995
MCCL; MCC:0000409
CLDB; cl4086
CLDB; cl4088
CLDB; cl4089
CLDB; cl4090
CLDB; cl4091
CLDB; cl4092
CLDB; cl4990
CCRID; 1101HUM-PUMC000046
CCRID; 1102HUM-NIFDC00025
CCRID; 3101HUMTCHu44
CCRID; 4201HUM-CCTCC00191
Cell_Model_Passport; SIDM00844
CGH-DB; 9204-4
Cosmic-CLP; 909262
DepMap; ACH-000654
DSMZCellDive; ACC-319
IHW; IHW04994
IGRhCellID; Raji
IPD-IMGT/HLA; 11295
LINCS_LDP; LCL-2025
Lonza; 726
TOKU-E; 2967
Anatomy/cell type resourcesBTO; BTO:0001154
Biological sample resourcesBioSample; SAMN01821589
BioSample; SAMN01821656
BioSample; SAMN01821715
BioSample; SAMN01821738
BioSample; SAMN03473128
BioSample; SAMN10987653
ENCODE; ENCBS260AAA
Cell line collections (Providers)Abcam; ab271145
Abcam; ab275473
AddexBio; C0003009/4668
ATCC; CCL-86
ATCC; CRL-7936 - Discontinued
BCRC; 60116
BCRJ; 0211
CCTCC; GDC0191
CLS; 300359
Coriell; GM04671
DSMZ; ACC-319
ECACC; 85011429
HIVReagentProgram; ARP-9944
ICLC; HTL00002
IZSLER; BS TCL 54
JCRB; IFO50046
JCRB; JCRB9012
NCBI_Iran; C127
RCB; RCB1647
RCB; RCB3673
TKG; TKG 0371
Chemistry resourcesChEMBL-Cells; CHEMBL3307663
ChEMBL-Targets; CHEMBL614628
GDSC; 909262
PharmacoDB; Raji_1282_2019
PubChem_Cell_line; CVCL_0511
Encyclopedic resourcesWikidata; Q4215980
Experimental variables resourcesEFO; EFO_0002324

更多>>相关产品

总部地址:北京市怀柔区渤海镇怀沙路536号

关注我们
在线咨询
在线客服
电话咨询
微信客服
返回顶部